Kindred Healthcare, Inc. (NYSE:KND) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Wednesday.

According to Zacks, “Kindred Healthcare, Inc. is one of the largest providers of long-term healthcare services in the United States. Their health services division provides long-term care services by operating nursing centers and a rehabilitation therapy business, and their hospital division provides long-term acute care services by operating hospitals and an institutional pharmacy business. “

Other equities research analysts have also recently issued research reports about the company. BidaskClub cut Kindred Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, July 31st. Royal Bank Of Canada dropped their price objective on Kindred Healthcare from $9.00 to $7.50 and set a “sector perform” rating on the stock in a research note on Thursday, September 21st. Mizuho reiterated a “neutral” rating and set a $9.00 price objective on shares of Kindred Healthcare in a research note on Monday, July 3rd. Deutsche Bank AG reiterated a “hold” rating and set a $9.00 price objective (down previously from $10.00) on shares of Kindred Healthcare in a research note on Monday, September 18th. Finally, Bank of America Corporation dropped their price objective on Kindred Healthcare from $7.50 to $6.50 and set an “underperform” rating on the stock in a research note on Thursday, September 21st. Six equities research analysts have rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $8.94.

Kindred Healthcare (NYSE KND) traded down 6.29% during mid-day trading on Wednesday, hitting $6.70. 1,837,322 shares of the stock were exchanged. The firm has a 50-day moving average price of $7.21 and a 200-day moving average price of $9.08. Kindred Healthcare has a 12-month low of $5.50 and a 12-month high of $11.90. The stock’s market capitalization is $583.03 million.

Kindred Healthcare (NYSE:KND) last released its earnings results on Thursday, August 3rd. The health services provider reported $0.19 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.16 by $0.03. The firm had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Kindred Healthcare had a negative return on equity of 80.03% and a negative net margin of 7.06%. The business’s quarterly revenue was down 4.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.38 EPS. Equities analysts predict that Kindred Healthcare will post $0.35 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Kindred Healthcare, Inc. (KND) Lowered to “Sell” at Zacks Investment Research” was posted by American Banking News and is the property of of American Banking News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2017/10/04/kindred-healthcare-inc-knd-lowered-to-sell-at-zacks-investment-research.html.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Public Employees Retirement System of Ohio grew its holdings in Kindred Healthcare by 10.2% in the 2nd quarter. Public Employees Retirement System of Ohio now owns 26,773 shares of the health services provider’s stock valued at $312,000 after buying an additional 2,468 shares in the last quarter. Piedmont Investment Advisors LLC acquired a new position in Kindred Healthcare in the 2nd quarter valued at $216,000. Sterling Capital Management LLC acquired a new position in Kindred Healthcare in the 2nd quarter valued at $1,063,000. Bank of Nova Scotia grew its holdings in Kindred Healthcare by 232.3% in the 2nd quarter. Bank of Nova Scotia now owns 876,317 shares of the health services provider’s stock valued at $10,209,000 after buying an additional 612,598 shares in the last quarter. Finally, Glenview Capital Management LLC grew its holdings in Kindred Healthcare by 18.8% in the 2nd quarter. Glenview Capital Management LLC now owns 2,374,713 shares of the health services provider’s stock valued at $27,665,000 after buying an additional 375,000 shares in the last quarter. 88.14% of the stock is currently owned by hedge funds and other institutional investors.

About Kindred Healthcare

Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Get a free copy of the Zacks research report on Kindred Healthcare (KND)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Kindred Healthcare (NYSE:KND)

Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.